These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29028555)

  • 41. Risk and benefit perceptions of party drug use.
    White B; Degenhardt L; Breen C; Bruno R; Newman J; Proudfoot P
    Addict Behav; 2006 Jan; 31(1):137-42. PubMed ID: 15907371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA.
    Haug NA; Wadekar R; Barry R; Sottile J
    J Psychoactive Drugs; 2024; 56(3):412-421. PubMed ID: 37384948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is the use of ecstasy and hallucinogens increasing? Results from a community study.
    Schuster P; Lieb R; Lamertz C; Wittchen HU
    Eur Addict Res; 1998 Mar; 4(1-2):75-82. PubMed ID: 9740820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in prevalence, socio-behavioral correlates, and psychosocial distress between club drug and hard drug use in Taiwan: Results from the 2014 National Survey of Substance Use.
    Chen WJ; Wu SC; Tsay WI; Chen YT; Hsiao PC; Yu YH; Ting TT; Chen CY; Tu YK; Huang JH; Yang HJ; Li CY; Strong C; Yen CF; Yen CF; Hsu J
    Int J Drug Policy; 2017 Oct; 48():99-107. PubMed ID: 28810160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns and perceptions of ecstasy use among young, low-income women.
    Wu ZH; Holzer CE; Breitkopf CR; Grady JJ; Berenson AB
    Addict Behav; 2006 Apr; 31(4):676-85. PubMed ID: 16005160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ecstasy use and its association with sexual behaviors among drug users in New York City.
    Novoa RA; Ompad DC; Wu Y; Vlahov D; Galea S
    J Community Health; 2005 Oct; 30(5):331-43. PubMed ID: 16175956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sexual identity and drug use harm among high-risk, active substance users.
    Chow C; Vallance K; Stockwell T; Macdonald S; Martin G; Ivsins A; Marsh DC; Michelow W; Roth E; Duff C
    Cult Health Sex; 2013; 15(3):311-26. PubMed ID: 23311592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tracking ecstasy trends in the United States with data from three national drug surveillance systems.
    Yacoubian GS
    J Drug Educ; 2003; 33(3):245-58. PubMed ID: 15022859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.
    Winstock AR; Kaar S; Borschmann R
    J Psychopharmacol; 2014 Jan; 28(1):49-54. PubMed ID: 24284475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polydrug Use Typologies of Regular Ecstasy Users Visiting Electronic Dance Music Events: A Latent Class Analysis.
    van Beek RJJ; Blankers M; Kleinjan M; Waldron J; Grabski M; Freeman T; Curran V; van der Pol P; van Laar M
    Eur Addict Res; 2024; 30(1):52-64. PubMed ID: 38154456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.
    Wu LT; Parrott AC; Ringwalt CL; Patkar AA; Mannelli P; Blazer DG
    Addict Behav; 2009 Aug; 34(8):654-61. PubMed ID: 19361931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Getting into ecstasy: comparing moderate and heavy young adult users.
    Sterk CE; Theall KP; Elifson KW
    J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
    Parrott AC; Buchanan T; Scholey AB; Heffernan T; Ling J; Rodgers J
    Hum Psychopharmacol; 2002 Aug; 17(6):309-12. PubMed ID: 12404677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Club drug use and dependence among young adults recruited through time-space sampling.
    Parsons JT; Grov C; Kelly BC
    Public Health Rep; 2009; 124(2):246-54. PubMed ID: 19320366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Illicit drug use among New Zealand gay and bisexual men: Prevalence and association with sexual health behaviours.
    Saxton P; Newcombe D; Ahmed A; Dickson N; Hughes A
    Drug Alcohol Rev; 2018 Feb; 37(2):180-187. PubMed ID: 28439922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females.
    Cance JD; Ashley OS; Penne MA
    J Adolesc Health; 2005 Nov; 37(5):409. PubMed ID: 16227128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.
    Southey M; Kathirgamalingam A; Crawford B; Kaul R; McNamara J; John-Leader F; Heslop J; Pit SW
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):55. PubMed ID: 32758263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
    Falck RS; Carlson RG; Wang J; Siegal HA
    Drug Alcohol Depend; 2004 Apr; 74(1):45-54. PubMed ID: 15072806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.